Skip to main content

Peer Review reports

From: Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)

Original Submission
22 Aug 2021 Submitted Original manuscript
11 Sep 2021 Reviewed Reviewer Report
15 Sep 2021 Reviewed Reviewer Report
31 Oct 2021 Author responded Author comments - Kerstin Maria Kampa-Schittenhelm
Resubmission - Version 2
31 Oct 2021 Submitted Manuscript version 2
19 Nov 2021 Author responded Author comments - Kerstin Maria Kampa-Schittenhelm
Resubmission - Version 3
19 Nov 2021 Submitted Manuscript version 3
28 Nov 2021 Author responded Author comments - Kerstin Maria Kampa-Schittenhelm
Resubmission - Version 4
28 Nov 2021 Submitted Manuscript version 4
7 Dec 2021 Reviewed Reviewer Report
24 Dec 2021 Reviewed Reviewer Report
23 Jan 2022 Author responded Author comments - Kerstin Maria Kampa-Schittenhelm
Resubmission - Version 5
23 Jan 2022 Submitted Manuscript version 5
7 Feb 2022 Author responded Author comments - Kerstin Maria Kampa-Schittenhelm
Resubmission - Version 6
7 Feb 2022 Submitted Manuscript version 6
25 Mar 2022 Reviewed Reviewer Report
8 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
11 Apr 2022 Editorially accepted
2 Jul 2022 Article published 10.1186/s12885-022-09726-7

You can find further information about peer review here.

Back to article page